
  
    
      
        Abstract_NNP
        
          Introduction_NNP
          In_IN cancer_NN the_DT gelatinases_NNS [_NN matrix_NN metalloproteinase_NN
          (_( MMP_NNP )_) -_: 2_CD and_CC MMP-_NNP 9_CD ]_NN have_VBP been_VBN shown_VBN to_TO be_VB associated_VBN with_IN
          tissue_NN invasion_NN and_CC metastatic_JJ disease_NN ._. In_IN patients_NNS with_IN
          inflammatory_JJ arthritis_NN the_DT gelatinases_NNS are_VBP expressed_VBN in_IN
          the_DT synovial_NN membrane_NN ,_, and_CC have_VBP been_VBN implicated_VBN in_IN
          synovial_NN tissue_NN invasion_NN into_IN adjacent_JJ cartilage_NN and_CC
          bone_NN ._. It_PRP is_VBZ hypothesized_VBN that_IN an_DT imbalance_NN between_IN the_DT
          activators_NNS and_CC inhibitors_NNS of_IN the_DT gelatinases_NNS results_NNS in_IN
          higher_JJR levels_NNS of_IN activity_NN ,_, enhanced_VBD local_JJ proteolysis_NNS ,_,
          and_CC bone_NN erosion_NN ._.
        
        
          Objectives_NNP
          To_TO determine_VB whether_IN the_DT expression_NN and_CC activity_NN
          levels_NNS of_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD ,_, and_CC their_PRP$ regulators_NNS MMP-_NNP 14_CD
          and_CC tissue_NN inhibitor_NN of_IN metalloproteinase_NN (_( TIMP_NNP )_) ,_, are_VBP
          associated_VBN with_IN early_JJ erosion_NN formation_NN in_IN patients_NNS with_IN
          synovitis_NNS of_IN recent_JJ onset_NN ._.
        
        
          Patients_NNS and_CC method_NN
          A_DT subset_NN of_IN 66_CD patients_NNS was_VBD selected_VBN from_IN a_DT larger_JJR
          early_JJ synovitis_NNS cohort_NN on_IN the_DT basis_NN of_IN tissue_NN
          availability_NN for_IN the_DT study_NN of_IN synovial_NN tissue_NN and_CC serum_NN
          gelatinase_NN expression_NN ._. Patients_NNS with_IN peripheral_JJ joint_JJ
          synovitis_NNS of_IN less_JJR than_IN 1_CD years_NNS '_POS duration_NN were_VBD evaluated_VBN
          clinically_RB and_CC serologically_RB on_IN four_CD visits_NNS over_IN a_DT period_NN
          of_IN 12_CD months_NNS ._. At_IN the_DT initial_JJ visit_NN ,_, patients_NNS underwent_VBD a_DT
          synovial_NN tissue_NN biopsy_NN of_IN one_CD swollen_JJ joint_NN ,_, and_CC patients_NNS
          had_VBD radiographic_JJ evaluation_NN of_IN hands_NNS and_CC feet_NNS initially_RB
          and_CC at_IN 1_CD year_NN ._. Serum_NNP MMP-_NNP 1_CD ,_, MMP-_NNP 2_CD ,_, MMP-_NNP 9_CD ,_, MMP-_NNP 14_CD ,_, and_CC
          TIMP-_NNP 1_CD and_CC TIMP-_NNP 2_CD levels_NNS were_VBD determined_VBN ,_, and_CC synovial_NN
          tissue_NN was_VBD examined_VBN by_IN immunohistology_NN for_IN the_DT expression_NN
          of_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD ,_, and_CC their_PRP$ molecular_JJ regulators_NNS ._.
          Gelatinolytic_NNP activity_NN for_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD was_VBD quantified_VBN
          using_VBG a_DT sensitive_JJ ,_, tissue-based_JJ gel_NN zymography_NN technique_NN ._.
          Four_CD healthy_JJ individuals_NNS underwent_VBD closed_VBN synovial_NN biopsy_NN
          and_CC their_PRP$ synovial_NN tissues_NNS were_VBD similarly_RB analyzed_VBN ._.
        
        
          Results_NNS
          Of_IN the_DT 66_CD patients_NNS studied_VBN ,_, 45_CD fulfilled_VBN American_NNP
          College_NNP of_IN Rheumatology_NNP criteria_NNS for_IN rheumatoid_NN arthritis_NN
          (_( RA_NNP )_) ,_, with_IN 32_CD (_( 71_CD %_NN )_) being_VBG rheumatoid_NN factor_NN positive_JJ ._. Of_IN
          the_DT 21_CD non-_NN RA_NNP patients_NNS ,_, seven_CD had_VBD a_DT spondylarthropathy_NN
          and_CC 14_CD had_VBD undifferentiated_JJ arthritis_NN ._. Radiographically_NNP ,_,
          12_CD of_IN the_DT RA_NNP patients_NNS had_VBD erosions_NNS at_IN multiple_JJ sites_NNS by_IN 1_CD
          year_NN ,_, whereas_IN none_NN of_IN the_DT non-_NN RA_NNP patients_NNS had_VBD developed_VBN
          erosive_JJ disease_NN of_IN this_DT extent_NN ._. In_IN the_DT tissue_NN ,_, latent_NN
          MMP-_NNP 2_CD was_VBD widely_RB expressed_VBN in_IN the_DT synovial_NN lining_NN layer_NN
          and_CC in_IN areas_NNS of_IN stromal_NN proliferation_NN in_IN the_DT sublining_VBG
          layer_NN and_CC stroma_NN ,_, whereas_IN MMP-_NNP 9_CD was_VBD expressed_VBN more_RBR
          sparsely_RB and_CC focally_RB ._. MMP-_NNP 14_CD ,_, TIMP-_NNP 2_CD ,_, and_CC MMP-_NNP 2_CD were_VBD all_DT
          detected_VBD in_IN similar_JJ areas_NNS of_IN the_DT lining_NN layer_NN on_IN
          consecutive_JJ histologic_JJ sections_NNS ._. Tissue_NNP expression_NN of_IN
          MMP-_NNP 14_CD ,_, the_DT activator_NN for_IN pro-_JJ MMP-_NNP 2_CD ,_, was_VBD significantly_RB
          higher_JJR in_IN RA_NNP than_IN in_IN non-_NN RA_NNP patients_NNS (_( 8_CD ._. 4_LS ±_NN 5_CD versus_CC 3_CD ._. 7_CD
          ±_NN 4_CD cells_NNS /_NN high-power_JJ field_NN ;_: 
          P_NN =_SYM 0_CD ._. 009_CD )_) ._. In_IN contrast_NN ,_, the_DT
          expression_NN of_IN TIMP-_NNP 2_CD ,_, an_DT inhibitor_NN of_IN MMP-_NNP 2_CD ,_, was_VBD lower_JJR in_IN
          the_DT RA_NNP than_IN in_IN the_DT non-_NN RA_NNP samples_NNS (_( 25_CD ±_NN 12_CD versus_CC 39_CD ±_NN 9_CD
          cells_NNS /_NN high-power_JJ field_NN ;_: 
          P_NN =_SYM 0_CD ._. 01_CD )_) ._. Synovial_NNP tissue_NN
          expressions_NNS of_IN MMP-_NNP 2_CD ,_, MMP-_NNP 14_CD ,_, and_CC TIMP-_NNP 2_CD were_VBD virtually_RB
          undetectable_JJ in_IN normal_JJ synovial_NN tissue_NN samples_NNS ._. The_DT
          synovial_NN tissue_NN samples_NNS of_IN patients_NNS with_IN erosive_JJ disease_NN
          had_VBD significantly_RB higher_JJR levels_NNS of_IN active_JJ MMP-_NNP 2_CD than_IN did_VBD
          those_DT of_IN patients_NNS without_IN erosions_NNS (_( Fig_NNP ._. 1_LS )_) ._. Tissue_NNP
          expression_NN of_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD ,_, however_RB ,_, did_VBD not_RB correlate_VBP
          with_IN the_DT serum_NN levels_NNS of_IN these_DT enzymes_NNS ._.
          With_IN the_DT exception_NN of_IN serum_NN MMP-_NNP 2_CD ,_, which_WDT was_VBD not_RB
          elevated_VBD over_IN normal_JJ ,_, serum_NN levels_NNS of_IN all_DT of_IN the_DT other_JJ
          MMPs_NNP and_CC TIMPs_NNP were_VBD elevated_VBD to_TO varying_VBG degrees_NNS ,_, and_CC were_VBD
          not_RB predictive_JJ of_IN erosive_JJ disease_NN ._. Interestingly_RB ,_, MMP-_NNP 1_CD
          and_CC C-_NNP reactive_JJ protein_NN ,_, both_DT of_IN which_WDT were_VBD associated_VBN
          with_IN the_DT presence_NN of_IN erosions_NNS ,_, were_VBD positively_RB correlated_JJ
          with_IN each_DT other_JJ (_( 
          r_LS =_SYM 0_CD ._. 42_CD ;_: 
          P_NN <_NN 0_CD ._. 001_CD )_) ._.
        
        
          Discussion_NNP
          MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD are_VBP thought_VBN to_TO play_VB an_DT important_JJ role_NN
          in_IN the_DT evolution_NN of_IN joint_JJ erosions_NNS in_IN patients_NNS with_IN an_DT
          inflammatory_JJ arthritis_NN ._. Most_JJS studies_NNS have_VBP concentrated_VBN on_IN
          the_DT contribution_NN of_IN MMP-_NNP 9_CD to_TO the_DT synovitis_NNS ,_, because_IN
          synovial_NN fluid_NN and_CC serum_NN MMP-_NNP 9_CD levels_NNS are_VBP markedly_RB
          increased_VBN in_IN inflammatory_JJ arthropathies_NNS ._. Previously_RB
          reported_VBD serum_NN levels_NNS of_IN MMP-_NNP 9_CD have_VBP varied_VBN widely_RB ._. In_IN the_DT
          present_JJ sample_NN of_IN patients_NNS with_IN synovitis_NNS of_IN recent_JJ
          onset_NN ,_, serum_NN MMP-_NNP 9_CD levels_NNS were_VBD elevated_VBD in_IN only_RB 21_CD %_NN ._.
          Moreover_RB ,_, these_DT elevations_NNS were_VBD not_RB specific_JJ for_IN RA_NNP ,_, the_DT
          tissue_NN expression_NN of_IN MMP-_NNP 9_CD was_VBD focal_JJ ,_, and_CC the_DT levels_NNS of_IN
          MMP-_NNP 9_CD activity_NN were_VBD not_RB well_RB correlated_JJ with_IN early_JJ
          erosions_NNS ._. Although_IN serum_NN MMP-_NNP 2_CD levels_NNS were_VBD not_RB of_IN
          prognostic_JJ value_NN ,_, high_JJ synovial_NN tissue_NN levels_NNS of_IN MMP-_NNP 2_CD
          activity_NN were_VBD significantly_RB correlated_JJ with_IN the_DT presence_NN
          of_IN early_JJ erosions_NNS ._. This_DT may_MD reflect_VB augmented_JJ activation_NN
          of_IN MMP-_NNP 2_CD by_IN the_DT relatively_RB high_JJ levels_NNS of_IN MMP-_NNP 14_CD and_CC low_JJ
          levels_NNS of_IN TIMP-_NNP 2_CD seen_VBN in_IN these_DT tissues_NNS ._. We_PRP were_VBD able_JJ to_TO
          localize_NN the_DT components_NNS of_IN this_DT trimolecular_NN complex_JJ to_TO
          the_DT synovial_NN lining_NN layer_NN in_IN consecutive_JJ tissue_NN sections_NNS ,_,
          a_DT finding_VBG that_WDT is_VBZ consistent_JJ with_IN their_PRP$
          colocalization_NN ._.
          In_IN conclusion_NN ,_, we_PRP have_VBP provided_VBN evidence_NN that_IN active_JJ
          MMP-_NNP 2_CD complexes_NNS are_VBP detectable_JJ in_IN the_DT inflamed_JJ RA_NNP
          synovium_NN and_CC may_MD be_VB involved_VBN in_IN the_DT development_NN of_IN early_JJ
          bony_NN erosions_NNS ._. These_DT results_NNS suggest_VBP that_IN strategies_NNS to_TO
          inhibit_VB the_DT activation_NN of_IN MMP-_NNP 2_CD may_MD have_VB the_DT potential_NN
          for_IN retarding_VBG or_CC preventing_VBG early_JJ erosions_NNS in_IN patients_NNS
          with_IN inflammatory_JJ arthritis_NN ._.
        
      
      
        Introduction_NNP
        Radiographic_NNP erosions_NNS are_VBP characteristic_NN of_IN a_DT number_NN of_IN
        chronic_JJ inflammatory_JJ arthropathies_NNS ,_, and_CC are_VBP associated_VBN with_IN
        articular_NN destruction_NN leading_VBG to_TO functional_JJ loss_NN and_CC
        disability_NN [_NN 1_CD ,_, 2_CD ]_NN ._. The_DT prevention_NN or_CC retardation_NN of_IN
        erosions_NNS is_VBZ a_DT major_JJ objective_NN for_IN early_JJ therapeutic_JJ
        interventions_NNS in_IN patients_NNS with_IN new_JJ onset_NN arthritis_NN [_NN 3_CD ]_NN ._.
        Although_IN the_DT pathologic_JJ processes_NNS that_WDT underlie_VB the_DT
        development_NN of_IN erosions_NNS are_VBP incompletely_RB understood_VBN ,_, a_DT
        considerable_JJ body_NN of_IN evidence_NN has_VBZ suggested_VBN that_IN a_DT pannus_JJ
        of_IN cells_NNS that_WDT originate_VB in_IN chronically_RB inflamed_JJ ,_,
        proliferative_JJ synovial_NN tissue_NN becomes_VBZ locally_RB invasive_JJ ,_, and_CC
        enzymatically_RB degrades_NNS the_DT matrix_NN of_IN the_DT articular_NN
        cartilage_NN and_CC periarticular_NN bone_NN [_NN 4_CD ]_NN ._.
        Although_IN a_DT number_NN of_IN enzymes_NNS have_VBP been_VBN shown_VBN to_TO be_VB
        involved_VBN in_IN erosion_NN formation_NN ,_, several_JJ members_NNS of_IN the_DT
        matrix_NN metalloproteinase_NN (_( MMP_NNP )_) family_NN are_VBP thought_VBN to_TO play_VB a_DT
        central_JJ role_NN in_IN the_DT degradation_NN of_IN the_DT extracellular_NN matrix_NN
        of_IN articular_NN bone_NN and_CC cartilage_NN ._. Of_IN the_DT MMPs_NNP ,_, the_DT
        collagenases_NNS [_NN 5_CD ,_, 6_CD ]_NN and_CC stromelysins_NNS [_NN 7_CD ]_NN have_VBP been_VBN the_DT
        best_RBS studied_VBN ,_, and_CC marked_VBD elevations_NNS in_IN serum_NN and_CC synovial_NN
        levels_NNS have_VBP been_VBN found_VBN in_IN rheumatoid_NN arthritis_NN (_( RA_NNP )_) [_NN 8_CD ]_NN ._. A_DT
        number_NN of_IN studies_NNS have_VBP shown_VBN that_IN the_DT serum_NN and_CC synovial_NN
        levels_NNS of_IN both_DT gelatinases_NNS MMP-_NNP 2_CD [_NN 9_CD ,_, 10_CD ]_NN and_CC MMP-_NNP 9_CD [_NN 11_CD ,_,
        12_CD ,_, 13_CD ]_NN are_VBP similarly_RB elevated_VBD in_IN RA_NNP ._. Although_IN both_DT of_IN
        these_DT MMPs_NNP are_VBP expressed_VBN at_IN the_DT junction_NN between_IN synovial_NN
        pannus_JJ and_CC cartilage_NN or_CC bone_NN [_NN 14_CD ]_NN ,_, further_JJ evidence_NN of_IN
        their_PRP$ direct_JJ role_NN in_IN erosion_NN formation_NN is_VBZ lacking_VBG ._. In_IN
        addition_NN members_NNS of_IN this_DT subfamily_RB of_IN MMPs_NNP are_VBP involved_VBN in_IN
        the_DT invasiveness_NNS of_IN cancers_NNS [_NN 15_CD ,_, 16_CD ]_NN ,_, and_CC thus_RB may_MD also_RB
        play_VB a_DT similar_JJ role_NN in_IN the_DT invasion_NN of_IN synovial_NN pannus_JJ ._.
        The_DT regulation_NN of_IN MMP_NNP activity_NN is_VBZ complex_JJ ,_, and_CC occurs_VBZ at_IN
        multiple_JJ levels_NNS [_NN 17_CD ,_, 18_CD ,_, 19_CD ]_NN ._. In_IN most_JJS cases_NNS ,_, MMPs_NNP are_VBP
        secreted_JJ as_IN proenzymes_NNS and_CC then_RB undergo_VBP extracellular_NN
        activation_NN ._. Few_JJ studies_NNS have_VBP evaluated_VBN the_DT levels_NNS of_IN active_JJ
        MMPs_NNP 
        in_IN situ_NN ._. Gel_NNP zymography_NN has_VBZ proved_VBN
        to_TO be_VB a_DT sensitive_JJ and_CC effective_JJ method_NN of_IN detecting_VBG the_DT
        activity_NN of_IN gelatinases_NNS in_IN small_JJ tissue_NN samples_NNS [_NN 20_CD ]_NN ._. In_IN
        the_DT present_JJ study_NN we_PRP evaluated_VBD the_DT levels_NNS of_IN active_JJ MMP-_NNP 2_CD
        and_CC MMP-_NNP 9_CD in_IN small_JJ synovial_NN biopsy_NN samples_NNS obtained_VBN from_IN
        patients_NNS with_IN synovitis_NNS of_IN recent_JJ onset_NN ._. We_PRP also_RB examined_VBD
        the_DT synovial_NN expression_NN of_IN the_DT gelatinases_NNS by_IN
        immunohistology_NN ,_, as_RB well_RB as_IN their_PRP$ serum_NN levels_NNS in_IN order_NN to_TO
        determine_VB whether_IN these_DT indices_NNS may_MD predict_VB erosions_NNS in_IN RA_NNP
        patients_NNS ._.
      
      
        Patients_NNS and_CC method_NN
        
          Patient_NNP population_NN
          A_DT total_NN of_IN 66_CD patients_NNS that_WDT formed_VBD a_DT subset_NN of_IN a_DT
          larger_JJR early_JJ synovitis_NNS cohort_NN ,_, recruited_VBN into_IN an_DT ongoing_JJ
          US_NNP National_NNP Institutes_NNPS of_IN Health_NNP protocol_NN (_( 94_CD -_: AR-_NNP 0194_CD )_) ,_,
          were_VBD selected_VBN for_IN analysis_NN on_IN the_DT basis_NN of_IN having_VBG stored_VBN
          optimum_JJ cooling_NN temperature_NN (_( OCT_NNP )_) compound_NN samples_NNS
          available_JJ for_IN analysis_NN ._. The_DT patients_NNS had_VBD peripheral_JJ joint_JJ
          synovitis_NNS with_IN duration_NN longer_JJR than_IN 6_CD weeks_NNS but_CC less_JJR than_IN
          12_CD months_NNS ._. After_IN the_DT initial_JJ evaluation_NN they_PRP were_VBD
          followed_VBN prospectively_RB for_IN 12_CD months_NNS ._. Of_IN those_DT patients_NNS ,_,
          45_CD fulfilled_VBD the_DT American_NNP College_NNP of_IN Rheumatology_NNP
          criteria_NNS for_IN RA_NNP [_NN 21_CD ]_NN ,_, seven_CD patients_NNS fulfilled_VBD the_DT
          European_NNP Spondylarthropathy_NNP Study_NNP Group_NNP criteria_NNS for_IN
          spondylarthropathies_NNS [_NN 22_CD ]_NN ,_, and_CC 14_CD could_MD not_RB be_VB
          classified_VBN and_CC were_VBD diagnosed_VBN with_IN undifferentiated_JJ
          arthritis_NN ._.
          Serum_NNP aliquots_NNS obtained_VBN at_IN the_DT initial_JJ visit_NN were_VBD used_VBN
          for_IN the_DT analysis_NN of_IN serum_NN MMP_NNP and_CC tissue_NN inhibitor_NN of_IN
          metalloproteinase_NN (_( TIMP_NNP )_) levels_NNS ._. All_DT patients_NNS underwent_VBD a_DT
          closed_VBN needle_NN biopsy_NN of_IN synovial_NN tissue_NN [_NN 23_CD ]_NN from_IN an_DT
          inflamed_JJ joint_NN ,_, typically_RB a_DT knee_NN ._. Tender_NNP and_CC swollen_JJ
          joint_JJ counts_NNS were_VBD obtained_VBN from_IN 66_CD joint_JJ areas_NNS ;_: hips_NNS were_VBD
          excluded_VBN ._. Anterioposterior_NNP and_CC lateral_NN radiographs_NNS of_IN the_DT
          hands_NNS and_CC feet_NNS were_VBD obtained_VBN at_IN the_DT initial_JJ visit_NN and_CC at_IN
          1_CD -_: year_NN follow-up_JJ visit_NN ._. Radiographs_NNP were_VBD read_VBN by_IN
          experienced_VBN radiologists_NNS ,_, who_WP were_VBD unaware_JJ of_IN the_DT
          patient_NN 's_POS diagnosis_NN or_CC test_NN results_NNS ,_, and_CC were_VBD scored_VBN for_IN
          erosions_NNS ._. Erosions_NNP were_VBD defined_VBN as_IN unequivocal_NN loss_NN of_IN
          cortical_JJ and_CC subcortical_JJ bone_NN in_IN at_IN least_JJS two_CD different_JJ
          joints_NNS of_IN either_DT the_DT hands_NNS or_CC feet_NNS ._. Of_IN the_DT 66_CD patients_NNS
          who_WP underwent_VBD a_DT clinical_JJ evaluation_NN and_CC analysis_NN of_IN serum_NN
          MMP_NNP levels_NNS ,_, 28_CD had_VBD synovial_NN tissue_NN biopsies_NNS with_IN
          detectable_JJ lining_NN layer_NN and_CC large_JJ enough_JJ samples_NNS to_TO
          determine_VB MMP_NNP and_CC TIMP_NNP expression_NN by_IN gel_NN zymography_NN and_CC
          immunohistochemistry_NN ._.
          Healthy_JJ volunteers_NNS (_( 
          n_NN =_SYM 4_LS )_) were_VBD recruited_VBN under_IN the_DT
          same_JJ protocol_NN and_CC a_DT synovial_NN knee_NN biopsy_NN was_VBD performed_VBN
          once_RB signed_VBD informed_VBN consent_NN was_VBD obtained_VBN ._. These_DT tissues_NNS
          were_VBD also_RB assayed_JJ by_IN gel_NN zymography_NN and_CC stained_JJ
          immunohistochemically_RB ._.
        
        
          Antibodies_NNP and_CC gels_NNS
          Antibodies_NNP to_TO MMP-_NNP 2_CD (_( immunoglobulin_NN G_NNP 
          1_LS )_) ,_, MMP-_NNP 9_CD (_( immunoglobulin_NN G_NNP 
          1_LS )_) and_CC MMP-_NNP 14_CD (_( immunoglobulin_NN G_NNP 
          1_LS )_) were_VBD purchased_VBN from_IN Research_NNP
          Diagnostics_NNPS Inc_NNP (_( Flanders_NNP ,_, NJ_NNP ,_, USA_NNP )_) ._. The_DT TIMP-_NNP 2_CD
          (_( immunoglobulin_NN G_NNP 
          1_LS )_) antibody_NN was_VBD obtained_VBN from_IN
          Calbiochem_NNP (_( La_NNP Jolla_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. Polyclonalmouse_NNP
          immunoglobulin_NN G_NNP 
          1_CD was_VBD used_VBN as_IN negative_JJ controlin_NN the_DT
          staining_VBG experiments_NNS ._. Enzyme-linked_NNP immunosorbent_NN assay_NN
          (_( ELISA_NNP )_) kits_NNS for_IN serum_NN MMP-_NNP 1_CD ,_, TIMP-_NNP 1_CD and_CC TIMP-_NNP 2_CD ,_, and_CC the_DT
          activity_NN assays_NNS for_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD were_VBD purchased_VBN from_IN
          Biotrak_NNP (_( Amersham_NNP Pharmacia_NNP Biotech_NNP ,_, Piscataway_NNP ,_, NJ_NNP ,_,
          USA_NNP )_) ._. Precast_NNP zymography_NN gels_NNS containing_VBG 10_CD %_NN Tris_NNP glycine_NN
          with_IN 0_CD ._. 1_CD %_NN gelatin_NN as_IN substrate_NN were_VBD purchased_VBN from_IN Novex_NNP
          (_( San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) ,_, and_CC protein_NN quantification_NN kits_NNS
          were_VBD purchased_VBN from_IN Bio-_NNP Rad_NNP Laboratories_NNPS (_( Hercules_NNP ,_, CA_NNP ,_,
          USA_NNP )_) ._.
        
        
          Matrix_NNP metalloproteinase_NN and_CC tissue_NN inhibitor_NN of_IN
          metalloproteinase_NN enzyme-linked_JJ immunosorbent_NN
          assay_NN
          ELISA_NNP assays_NNS for_IN MMP-_NNP 1_CD ,_, TIMP-_NNP 1_CD ,_, and_CC TIMP-_NNP 2_CD were_VBD
          performed_VBN according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._.
          Briefly_NNP ,_, 100_CD μ_NN l_NN diluted_VBD serum_NN samples_NNS were_VBD pipetted_JJ in_IN
          duplicates_NNS into_IN the_DT appropriate_JJ ELISA_NNP microtiter_NN wells_NNS
          and_CC incubated_JJ for_IN 2_CD h_NN at_IN 20_CD -_: 25_CD °_NN C_NNP ._. Wells_NNP were_VBD washed_VBN and_CC
          incubated_JJ with_IN 100_CD μl_NN of_IN the_DT antiserum_NN for_IN 2_CD h_NN at_IN
          20_CD -_: 25_CD °_NN C_NNP ,_, and_CC incubated_JJ with_IN 100_CD μl_NN of_IN the_DT peroxidase_NN
          conjugate_NN for_IN 1_CD h_NN ._. After_IN washing_VBG 100_CD μl_NN of_IN 3_CD ,_, 3_CD '_POS ,_, 5_CD ,_, 5_CD '_POS
          -_: tetramethylbenzi-dine_JJ /_NN hydrogen_NN peroxide_NN substrate_NN were_VBD
          pipetted_JJ into_IN the_DT wells_NNS and_CC incubated_JJ for_IN 30_CD min_NN at_IN room_NN
          temperature_NN ._. Absorbance_NNP at_IN 630_CD nm_NN was_VBD measured_VBN
          spectrophotometrically_RB in_IN an_DT automated_VBN plate_NN reader_NN ._.
        
        
          Serum_NNP matrix_NN metalloproteinase_NN activity_NN
          assays_NNS
          Active_JJ and_CC total_JJ MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD were_VBD measured_VBN by_IN
          activity_NN assays_NNS ._. Assays_NNP were_VBD performed_VBN according_VBG to_TO the_DT
          manufacturer_NN 's_POS instructions_NNS ._. Briefly_NNP ,_, 100_CD μl_NN diluted_VBD
          serum_NN samples_NNS were_VBD plated_JJ in_IN quadruplicate_NN and_CC
          refrigerated_JJ at_IN 4_CD °_NN C_NNP overnight_JJ ._. Plates_NNP were_VBD washed_VBN in_IN an_DT
          automated_VBN plate_NN washer_NN and_CC 50_CD μl_NN of_IN a_DT 1_CD mol_NN /_NN l_NN
          p-aminophenylmercuric_JJ acetate_NN ,_, which_WDT activates_NNS pro-_JJ MMP_NNP ,_,
          was_VBD added_VBN only_RB into_IN duplicate_VB wells_NNS in_IN which_WDT total_JJ MMP_NNP
          activity_NN was_VBD to_TO be_VB measured_VBN ._. After_IN 2_CD h_NN of_IN incubation_NN at_IN
          37_CD °_NN C_NNP ,_, 50_CD μl_NN detection_NN reagent_NN containing_VBG a_DT modified_VBN
          urokinase_NN and_CC S-_NNP 2444_CD peptide_NN substrate_NN was_VBD added_VBN to_TO all_DT
          wells_NNS ._. Plates_NNP were_VBD read_VBN spectrophotometrically_RB at_IN time_NN 0_CD
          and_CC after_IN a_DT 2_CD -_: h_NN incubation_NN at_IN 37_CD ºC_NN for_IN 2_CD h_NN at_IN an_DT
          absorbance_NN of_IN 410_CD nm_NN ._. MMP_NNP activity_NN was_VBD represented_VBN by_IN the_DT
          change_NN of_IN absorbance_NN over_IN time_NN ._. These_DT values_NNS were_VBD
          compared_VBN with_IN a_DT standard_JJ curve_NN of_IN serial_NN dilutions_NNS of_IN a_DT
          known_VBN concentration_NN of_IN activated_VBN enzyme_NN ._. Normal_NNP range_NN of_IN
          values_NNS was_VBD provided_VBN by_IN the_DT manufacturer_NN ._.
        
        
          Gel_NNP zymography_NN
          Gel_NNP zymography_NN on_IN synovial_NN tissue_NN samples_NNS was_VBD
          performed_VBN according_VBG to_TO a_DT protocol_NN developed_VBN by_IN Kleiner_NNP 
          et_CC al_NN [_NN 20_CD ]_NN ._. Unfixed_NNP cryosections_NNS
          of_IN synovial_NN tissue_NN ,_, obtained_VBN from_IN closed_JJ needle_NN biopsies_NNS
          as_IN described_VBN above_IN ,_, were_VBD scraped_JJ off_IN the_DT slide_NN with_IN a_DT
          22_CD -_: gauge_VB needle_NN ,_, transferred_VBN into_IN a_DT microfuge_NN tube_NN ,_, and_CC
          vortexed_JJ ._. Media_NNP from_IN a_DT HT-_NNP 1080_CD fibrosarcoma_NN cell_NN line_NN was_VBD
          used_VBN as_IN a_DT positive_JJ control_NN for_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD activity_NN ._.
          Of_IN each_DT sample_NN suspension_NN ,_, 30_CD μl_NN were_VBD loaded_VBN onto_IN a_DT
          precast_NN sodium_NN dodecylsulfate-_NN polyacrylamide_NN gel_NN
          electrophoresis_NNS (_( SDS-PAGE_NNP )_) containing_VBG 0_CD ._. 1_CD %_NN gelatin_NN ._. After_IN
          electrophoresis_NNS ,_, gels_NNS were_VBD washed_VBN in_IN 2_CD ._. 5_CD %_NN Triton_NNP X_NNP for_IN 3_CD
          h_NN and_CC incubated_JJ at_IN 37_CD °_NN C_NNP in_IN low_JJ salt_NN collagenase_NN buffer_NN
          containing_VBG 50_CD mmol_NN /_NN l_NN Tris_NNP ,_, 0_CD ._. 2_CD mol_NN /_NN l_NN NaCl_NNP ,_, 5_CD mmol_NN /_NN l_NN
          anhydrous_JJ CaCl_NNP 
          2_CD ,_, and_CC 0_CD ._. 02_CD %_NN Brijdetergent_NNP ._. The_DT gels_NNS
          were_VBD subsequently_RB stained_JJ with_IN 0_CD ._. 5_CD %_NN Comassie_NNP blue_JJ
          (_( G-_NNP 250_CD )_) ,_, destained_JJ with_IN 30_CD %_NN methanol_NN and_CC 10_CD %_NN acetic_JJ acid_NN ,_,
          and_CC incubated_JJ in_IN 30_CD %_NN methanol_NN and_CC 5_CD %_NN glycerol_NN ._. They_PRP were_VBD
          dried_VBN between_IN cellophane_NN sheets_NNS ._. Areas_NNS of_IN gelatinase_NN
          activity_NN appeared_VBD as_IN nonstaining_VBG bands_NNS on_IN the_DT gels_NNS ._.
          The_DT zymography_NN gels_NNS were_VBD scanned_JJ and_CC analyzed_VBD using_VBG US_NNP
          National_NNP Institutes_NNPS of_IN Health_NNP Image_NN 1_CD ._. 6_CD software_NN ._.
          Integrated_NNP pixel_NN density_NN for_IN each_DT gelatinolytic_JJ band_NN was_VBD
          recorded_VBN and_CC reported_VBN in_IN volume_NN units_NNS of_IN pixel_NN intensity_NN
          ×_NN mm_NN 2_CD ._. Each_DT value_NN was_VBD normalized_JJ against_IN the_DT protein_NN
          concentration_NN ,_, determined_VBN by_IN a_DT protein_NN quantitation_NN kit_NN
          according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ,_, and_CC
          reported_VBD as_IN gelatinase_NN activity_NN in_IN nanograms_NNS per_IN
          milligrams_NNS of_IN protein_NN ._. Gelatinolytic_NNP bands_NNS at_IN 92_CD ,_, 72_CD ,_, and_CC
          62_CD kDA_NN represent_VB latent_NN MMP-_NNP 2_CD ,_, latent_NN MMP-_NNP 9_CD ,_, and_CC active_JJ
          MMP-_NNP 2_CD activity_NN ,_, respectively_RB ._.
        
        
          Immunohistochemistry_NNP
          Immunohistochemistry_NNP was_VBD performed_VBN according_VBG to_TO
          standard_JJ techniques_NNS [_NN 24_CD ]_NN ._. OCT-embedded_NNP synovial_NN tissue_NN
          was_VBD cryosectioned_JJ into_IN 8_CD -_: μm_NN thick_JJ sections_NNS and_CC acetone_NN
          fixed_VBN on_IN glass_NN slides_NNS ._. After_IN hydration_NN and_CC blocking_VBG of_IN
          endogenous_JJ peroxidase_NN activity_NN ,_, tissues_NNS were_VBD blocked_VBN with_IN
          a_DT dilution_NN of_IN human_NN and_CC goat_NN serum_NN ._. Sections_NNP were_VBD
          incubated_JJ with_IN primary_JJ antibody_NN at_IN the_DT following_JJ
          concentrations_NNS :_: MMP-_NNP 2_CD (_( 1_CD :_: 75_CD )_) ,_, MMP-_NNP 9_CD (_( 1_CD :_: 75_CD )_) ,_, TIMP-_NNP 2_CD (_( 1_CD
          :_: 75_CD )_) ,_, and_CC MMP-_NNP 14_CD (_( 1_CD :_: 30_CD )_) ._. Negative_JJ controls_NNS using_VBG
          either_CC mouse_NN immunoglobulin_NN G_NNP 
          1_CD antibodies_NNS or_CC no_DT primary_JJ antibody_NN
          were_VBD performed_VBN with_IN each_DT experiment_NN ._. Slides_NNS were_VBD washed_VBN
          and_CC incubated_JJ with_IN goat_NN antimouse_NN biotinylated_JJ antibody_NN
          at_IN a_DT 1_CD :_: 750_CD dilution_NN followed_VBN by_IN incubation_NN with_IN
          streptavidine_NN horseradish_NN peroxidase_NN ._. Slides_NNS were_VBD
          developed_VBN with_IN a_DT substrate_NN chromogen_NN solution_NN until_IN a_DT
          brown_JJ reaction_NN product_NN was_VBD observed_VBN ,_, then_RB counterstained_JJ
          with_IN hematoxylin_NN and_CC coverslipped_JJ ._.
        
        
          Histologic_NNP evaluation_NN of_IN the_DT synovial_NN tissue_NN
          Synovial_NNP tissues_NNS suitable_JJ for_IN analysis_NN were_VBD
          histologically_RB evaluated_VBN for_IN the_DT presence_NN and_CC degree_NN of_IN
          inflammation_NN ._. All_DT tissues_NNS were_VBD analyzed_VBN in_IN a_DT blinded_JJ
          manner_NN by_IN two_CD independent_JJ observers_NNS ._. Proliferation_NNP of_IN the_DT
          lining_NN layer_NN ,_, inflammatory_JJ cellular_JJ infiltration_NN of_IN the_DT
          sublining_VBG layer_NN ,_, lymphocytic_JJ aggregates_NNS ,_, and_CC stromal_NN
          proliferation_NN were_VBD scored_VBN semiquantitatively_RB from_IN 0_CD to_TO 3_CD
          in_IN five_CD high-power_JJ fields_NNS (_( HPFs_NNP ;_: 400_CD ×_NN )_) for_IN each_DT
          category_NN ._. Scores_NNS were_VBD added_VBN and_CC divided_VBN by_IN four_CD to_TO derive_VB
          a_DT tissue_NN composite_JJ index_NN ._. Tissue_NNP scores_NNS for_IN MMP_NNP
          expression_NN were_VBD obtained_VBN by_IN counting_VBG the_DT number_NN of_IN
          positive_JJ cells_NNS in_IN the_DT lining_NN layer_NN and_CC sublining_VBG layer_NN
          (_( one_CD HPF_NNP underneath_IN the_DT lining_NN layer_NN )_) in_IN five_CD
          representative_NN HPFs_NNP (_( 400_CD ×_NN )_) and_CC expressed_VBD as_IN positive_JJ
          cells_NNS /_NN HPF_NNP ._.
        
        
          Statistical_NNP methods_NNS
          Differences_NNS between_IN patient_NN groups_NNS were_VBD analyzed_VBN using_VBG
          χ_NN 2_CD ,_, analysis_NN of_IN variance_NN ,_, and_CC Kruskal-_NNP Wallis_NNP tests_NNS ._.
        
      
      
        Results_NNS
        
          Patient_NNP clinical_JJ features_NNS
          The_DT clinical_JJ features_NNS of_IN the_DT 66_CD patients_NNS studied_VBN are_VBP
          shown_VBN in_IN Table_NNP 1_CD ._. Patients_NNPS with_IN RA_NNP were_VBD older_JJR ,_, had_VBD more_JJR
          tender_NN and_CC swollen_JJ joints_NNS ,_, were_VBD rheumatoid_NN factor_NN
          positive_JJ ,_, and_CC were_VBD more_RBR likely_JJ to_TO be_VB on_IN disease-modifying_JJ
          antirheumatic_JJ drug_NN therapy_NN than_IN were_VBD non-_NN RA_NNP patients_NNS ._. Of_IN
          the_DT patients_NNS with_IN RA_NNP ,_, 12_CD had_VBD erosions_NNS at_IN multiple_JJ sites_NNS
          by_IN 1_CD year_NN ,_, whereas_IN none_NN of_IN the_DT non-_NN RA_NNP patients_NNS had_VBD
          developed_VBN definite_JJ erosions_NNS ._. Patient_NNP characteristics_NNS in_IN
          the_DT subset_NN of_IN 28_CD patients_NNS who_WP underwent_VBD synovial_NN tissue_NN
          immunohistology_NN and_CC gel_NN zymography_NN did_VBD not_RB differ_VB
          significantly_RB from_IN the_DT larger_JJR sample_NN (_( data_NNS not_RB
          shown_VBN )_) ._.
        
        
          Serum_NNP levels_NNS of_IN the_DT metalloproteinases_NNS and_CC their_PRP$
          inhibitors_NNS in_IN patients_NNS with_IN early_JJ synovitis_NNS
          MMP-_NNP 1_CD serum_NN concentrations_NNS in_IN all_DT 66_CD (_( 100_CD %_NN )_) patients_NNS
          examined_VBD were_VBD elevated_VBD ,_, as_IN were_VBD total_JJ MMP-_NNP 9_CD levels_NNS in_IN 14_CD
          (_( 21_CD %_NN )_) ,_, TIMP-_NNP 1_CD levels_NNS in_IN 65_CD (_( 98_CD %_NN )_) ,_, and_CC TIMP-_NNP 2_CD levels_NNS in_IN 14_CD
          (_( 21_CD %_NN )_) patients_NNS (_( Table_NNP 2_LS )_) ._. Serum_NNP levels_NNS were_VBD not_RB elevated_VBD
          over_IN the_DT normal_JJ range_NN provided_VBN by_IN the_DT manufacturer_NN ._.
          Patients_NNS with_IN erosive_JJ disease_NN had_VBD higher_JJR serum_NN MMP-_NNP 1_CD and_CC
          mean_VB C-_NNP reactive_JJ protein_NN (_( CRP_NNP )_) levels_NNS than_IN patients_NNS
          without_IN erosion_NN (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) ._. levels_NNS of_IN mmp-_NN 1_CD ,_, but_CC
          not_RB of_IN other_JJ mmps_NNS ,_, significantly_RB correlated_JJ with_IN the_DT 
          crp_NN levels_NNS (_( >_NN r_LS =_SYM 0_CD ._. 42_CD ;_: 
          P_NN <_NN 0_CD ._. 001_CD )_) ._. overall_JJ serum_NN mmp-_NN 2_CD
          and_CC mmp-_NN 9_CD levels_NNS did_VBD not_RB correlate_VBP with_IN tissue_NN expression_NN
          of_IN these_DT enzymes_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Localization_NNP of_IN MMP-_NNP 2_CD ,_, MMP-_NNP 9_CD ,_, MMP-_NNP 14_CD ,_, and_CC TIMP-_NNP 2_CD
          expression_NN in_IN synovial_NN tissue_NN
          Expressions_NNP of_IN MMP-_NNP 2_CD ,_, MMP-_NNP 9_CD ,_, MMP-_NNP 14_CD ,_, and_CC TIMP-_NNP 2_CD in_IN
          representative_NN locations_NNS in_IN the_DT synovial_NN tissue_NN specimens_NNS
          are_VBP shown_VBN in_IN Figure_NN 2_CD ._. Of_IN note_NN ,_, the_DT antibodies_NNS used_VBN to_TO
          detect_VB MMP-_NNP 2_CD recognized_VBN only_RB the_DT latent_NN zymogen_NN form_NN ._.
          MMP-_NNP 2_CD was_VBD widely_RB expressed_VBN in_IN the_DT synovial_NN lining_NN layer_NN
          and_CC in_IN areas_NNS of_IN stromal_NN proliferation_NN in_IN the_DT sublining_VBG
          and_CC stromal_NN layer_NN ._. MMP-_NNP 9_CD expression_NN was_VBD more_RBR focal_JJ and_CC
          was_VBD observed_VBN sparsely_RB in_IN the_DT lining_NN layer_NN and_CC in_IN the_DT
          endothelium_NN of_IN single_JJ vessels_NNS in_IN both_DT RA_NNP and_CC non-_NN RA_NNP
          tissues_NNS ._. MMP-_NNP 14_CD and_CC TIMP-_NNP 2_CD were_VBD detected_VBN primarily_RB in_IN the_DT
          lining_NN layer_NN on_IN consecutive_JJ tissue_NN sections_NNS ._.
        
        
          Comparisons_NNP of_IN tissue_NN levels_NNS of_IN MMP-_NNP 2_CD ,_, MMP-_NNP 9_CD ,_,
          MMP-_NNP 14_CD ,_, and_CC TIMP-_NNP 2_CD
          MMP_NNP expression_NN was_VBD assayed_JJ in_IN 21_CD RA_NNP tissues_NNS and_CC seven_CD
          non-_NN RA_NNP tissues_NNS ,_, and_CC results_NNS were_VBD compared_VBN among_IN groups_NNS
          and_CC with_IN tissues_NNS from_IN four_CD healthy_JJ volunteers_NNS without_IN
          evidence_NN of_IN an_DT arthropathy_NN or_CC traumatic_JJ injury_NN (_( Table_NNP 3_LS )_) ._.
          Tissue_NNP composite_JJ indices_NNS of_IN inflammation_NN were_VBD similar_JJ in_IN
          the_DT RA_NNP and_CC non-_NN RA_NNP tissues_NNS ._. Five_CD of_IN the_DT 21_CD RA_NNP patients_NNS had_VBD
          erosions_NNS at_IN multiple_JJ sites_NNS ,_, as_IN compared_VBN with_IN none_NN of_IN the_DT
          non-_NN RA_NNP patients_NNS ._. Synovial_NNP tissue_NN expressions_NNS of_IN MMP-_NNP 2_CD ,_,
          MMP-_NNP 14_CD ,_, and_CC TIMP-_NNP 2_CD were_VBD virtually_RB undetectable_JJ in_IN all_DT
          normal_JJ volunteers_NNS ;_: MMP-_NNP 9_CD expression_NN was_VBD observed_VBN in_IN an_DT
          isolated_VBN area_NN of_IN one_CD normal_JJ synovial_NN tissue_NN sample_NN ._.
          Tissue_NNP expression_NN for_IN MMP-_NNP 14_CD ,_, the_DT activator_NN for_IN
          pro-_JJ MMP-_NNP 2_CD ,_, was_VBD significantly_RB higher_JJR in_IN RA_NNP than_IN in_IN non-_NN RA_NNP
          patients_NNS (_( 8_CD ._. 4_LS ±_NN 5_CD versus_CC 3_CD ._. 7_CD ±_NN 4_CD cells_NNS /_NN HPF_NNP ;_: 
          P_NN =_SYM 0_CD ._. 009_CD )_) ._. In_IN contrast_NN ,_, the_DT
          expression_NN of_IN TIMP-_NNP 2_CD ,_, an_DT inhibitor_NN of_IN MMP-_NNP 2_CD ,_, was_VBD lower_JJR in_IN
          the_DT RA_NNP than_IN in_IN the_DT non-_NN RA_NNP samples_NNS (_( 25_CD ±_NN 12_CD versus_CC 39_CD ±_NN 9_CD
          cells_NNS /_NN HPF_NNP ;_: 
          P_NN =_SYM 0_CD ._. 01_CD )_) ._. Activated_NNP and_CC latent_NN
          MMP-_NNP 2_CD activities_NNS ,_, as_IN measured_VBN by_IN gel_NN zymography_NN ,_, tended_VBD
          to_TO be_VB higher_JJR overall_JJ in_IN the_DT RA_NNP patients_NNS than_IN in_IN the_DT
          non-_NN RA_NNP patients_NNS ,_, but_CC results_NNS were_VBD not_RB statistically_RB
          different_JJ ._.
        
        
          Radiographic_NNP erosions_NNS are_VBP associated_VBN with_IN higher_JJR
          MMP-_NNP 2_CD activity_NN in_IN the_DT synovial_NN tissue_NN
          The_DT results_NNS of_IN synovial_NN tissue_NN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD
          expressions_NNS were_VBD compared_VBN among_IN patients_NNS with_IN erosive_JJ
          disease_NN ,_, patients_NNS without_IN erosions_NNS ,_, and_CC normal_JJ volunteers_NNS
          (_( Fig_NNP ._. 1_LS )_) ._. Patients_NNS with_IN erosive_JJ disease_NN had_VBD significantly_RB
          higher_JJR synovial_NN levels_NNS of_IN total_JJ MMP-_NNP 2_CD (_( 10_CD ._. 9_CD ±_NN 8_CD ._. 1_CD versus_CC
          18_CD ._. 9_CD ±_NN 9_CD ._. 4_CD ng_NN /_NN mg_NN ;_: 
          P_NN =_SYM 0_CD ._. 04_CD )_) and_CC active_JJ MMP-_NNP 2_CD (_( 3_CD ._. 5_LS ±_NN
          2_CD ._. 1_CD versus_CC 1_CD ._. 9_CD ±_NN 2_CD ._. 5_CD ng_NN /_NN mg_NN ;_: 
          P_NN =_SYM 0_CD ._. 04_CD )_) than_IN patients_NNS without_IN
          erosions_NNS ._. Similarly_RB ,_, mean_VB MMP-_NNP 9_CD activity_NN was_VBD higher_JJR in_IN
          tissue_NN samples_NNS from_IN patients_NNS with_IN erosive_JJ disease_NN ,_, but_CC
          wide_JJ variations_NNS in_IN tissue_NN expression_NN resulted_VBD in_IN poor_JJ
          discrimination_NN between_IN groups_NNS ._. As_IN expected_VBN ,_, synovium_NN of_IN
          normal_JJ volunteers_NNS had_VBD significantly_RB lower_JJR MMP-_NNP 2_CD activity_NN
          than_IN that_DT of_IN the_DT patients_NNS (_( 5_CD ._. 7_CD ±_NN 0_CD ._. 7_CD versus_CC 12_CD ._. 3_LS ±_NN 8_CD ._. 7_CD
          ng_NN /_NN mg_NN ;_: 
          P_NN <_NN 0_CD ._. 05_CD )_) ._. this_DT trend_NN was_VBD also_RB
          observed_VBN for_IN mmp-_NN 9_CD ,_, but_CC did_VBD not_RB reach_VB statistical_JJ
          significance_NN ,_, probably_RB due_JJ to_TO the_DT very_RB wide_JJ standard_JJ
          deviation_NN (_( 4_CD ._. 0_CD ±_NN 1_CD ._. 3_CD versus_CC 28_CD ._. 6_CD ±_NN 71_CD ._. 2_LS ng_NN /_NN mg_NN in_IN normal_JJ
          individuals_NNS and_CC in_IN the_DT patients_NNS ,_, respectively_RB ;_: >_NN P_NN =_SYM
          0_CD ._. 07_CD )_) ._.
        
      
      
        Discussion_NNP
        Joint_NNP destruction_NN is_VBZ one_CD of_IN the_DT hallmarks_NNS of_IN erosive_JJ
        arthropathies_NNS and_CC leads_VBZ to_TO significant_JJ morbidity_NN and_CC
        disability_NN ._. Newer_NNP imaging_NN studies_NNS have_VBP concluded_VBN that_DT
        erosion_NN formation_NN can_MD occur_VB very_RB early_RB in_IN the_DT disease_NN [_NN
        25_CD ]_NN ._. Detailed_NNP pathologic_JJ studies_NNS ,_, although_IN generally_RB
        performed_VBN on_IN destroyed_VBN joints_NNS obtained_VBN at_IN the_DT time_NN of_IN
        arthroplasty_NN ,_, have_VBP suggested_VBN that_IN these_DT erosions_NNS result_VBP
        from_IN direct_JJ invasion_NN of_IN synovial_NN tissue_NN into_IN the_DT adjacent_JJ
        articular_NN bone_NN and_CC cartilage_NN ._. It_PRP has_VBZ been_VBN postulated_JJ that_IN
        the_DT locally_RB invasive_JJ cells_NNS that_WDT form_NN the_DT aggressive_JJ pannus_JJ
        have_VBP acquired_VBN a_DT transformed_VBN phenotype_NN ,_, and_CC analogies_NNS to_TO
        invasive_JJ cancer_NN cells_NNS have_VBP been_VBN made_VBN [_NN 26_CD ]_NN ._. Several_JJ
        metalloproteinases_NNS that_WDT are_VBP capable_JJ of_IN the_DT proteolytic_JJ
        degradation_NN of_IN extracellular_NN matrix_NN are_VBP thought_VBN to_TO play_VB a_DT
        major_JJ role_NN in_IN the_DT dissolution_NN of_IN the_DT bone_NN and_CC cartilage_NN
        matrix_NN ,_, allowing_VBG the_DT invasive_JJ cells_NNS to_TO migrate_VB into_IN the_DT
        stroma_NN across_IN cell_NN boundaries_NNS ._. Although_IN the_DT relative_JJ
        contribution_NN of_IN each_DT MMP_NNP to_TO this_DT process_NN remains_VBZ unclear_JJ ,_,
        the_DT gelatinases_NNS ,_, particularly_RB MMP-_NNP 2_CD ,_, appear_VBP to_TO play_VB a_DT
        prominent_JJ role_NN in_IN tissue_NN invasion_NN [_NN 16_CD ]_NN ._. In_IN patients_NNS with_IN
        arthritis_NN ,_, most_JJS studies_NNS have_VBP concentrated_VBN on_IN the_DT
        contribution_NN of_IN MMP-_NNP 9_CD to_TO the_DT underlying_VBG mechanism_NN of_IN joint_JJ
        destruction_NN ._. In_IN contrast_NN to_TO MMP-_NNP 2_CD ,_, MMP-_NNP 9_CD levels_NNS tend_VBP to_TO be_VB
        higher_JJR in_IN inflammatory_JJ arthropathies_NNS than_IN in_IN traumatic_JJ ,_,
        osteoarthritic_JJ ,_, and_CC tissue_NN repair_NN processes_VBZ [_NN 11_CD ,_, 12_CD ,_, 27_CD ]_NN ._.
        Furthermore_RB ,_, these_DT two_CD MMPs_NNP differ_VB in_IN tissue_NN distribution_NN
        and_CC transcriptional_NN regulation_NN ._. These_DT observations_NNS suggest_VBP
        that_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD may_MD contribute_VB differentially_RB to_TO the_DT
        pathophysiologic_JJ processes_NNS that_WDT lead_VBP to_TO joint_JJ
        destruction_NN ._.
        In_IN the_DT joint_NN ,_, MMP-_NNP 9_CD is_VBZ expressed_VBN in_IN macrophages_NNS in_IN the_DT
        synovial_NN lining_NN layer_NN ,_, in_IN vascular_NN endothelial_NN cells_NNS ,_,
        leukocytes_NNS ,_, chondrocytes_NNS ,_, and_CC osteoclasts_NNS ._. It_PRP is_VBZ also_RB
        expressed_VBN on_IN cultured_JJ fibroblasts_NNS and_CC on_IN activated_VBN
        fibroblasts_NNS 
        in_IN vivo_NN [_NN 11_CD ,_, 28_CD ]_NN ._. MMP-_NNP 9_CD is_VBZ inducible_JJ
        by_IN inflammatory_JJ cytokines_NNS such_JJ as_IN tumor_NN necrosis_NNS factor-α_JJ
        and_CC interleukin-_NN 1_CD [_NN 19_CD ,_, 29_CD ]_NN ,_, and_CC the_DT post-transcriptional_JJ
        regulation_NN 
        in_IN vivo_NN remains_VBZ incompletely_RB
        understood_VBN ._. MMP-_NNP 9_CD is_VBZ secreted_JJ in_IN an_DT inactive_JJ zymogen_NN form_NN
        and_CC can_MD be_VB activated_VBN 
        in_IN vitro_NN by_IN the_DT plasmin_NN cascade_NN and_CC
        through_IN other_JJ MMPs_NNP [_NN 30_CD ,_, 31_CD ,_, 32_CD ,_, 33_CD ]_NN ._. In_IN its_PRP$ inactive_JJ form_NN
        MMP-_NNP 9_CD is_VBZ complexed_JJ to_TO TIMP-_NNP 1_CD [_NN 34_CD ]_NN ._. The_DT regulation_NN of_IN MMPs_NNP
        by_IN inflammatory_JJ cytokines_NNS ,_, and_CC the_DT expression_NN of_IN MMP-_NNP 9_CD in_IN
        macrophages_NNS and_CC vascular_NN structures_NNS have_VBP previously_RB
        suggested_VBN that_IN MMP-_NNP 9_CD may_MD be_VB associated_VBN with_IN the_DT synovial_NN
        inflammation_NN and_CC neovascularization_NN [_NN 35_CD ,_, 36_CD ]_NN ._.
        In_IN contrast_NN to_TO MMP-_NNP 9_CD ,_, MMP-_NNP 2_CD ,_, in_IN the_DT inactive_JJ zymogen_NN
        form_NN ,_, is_VBZ constitutively_RB expressed_VBN by_IN many_JJ cell_NN types_NNS ,_,
        including_VBG fibroblasts_NNS and_CC endothelial_NN cells_NNS ,_, and_CC is_VBZ
        involved_VBN in_IN many_JJ aspects_NNS of_IN normal_JJ tissue_NN remodeling_NN and_CC
        angiogenesis_NNS [_NN 37_CD ,_, 38_CD ]_NN ._. Its_PRP$ unique_JJ regulatory_JJ requirements_NNS
        at_IN the_DT cell_NN surface_NN have_VBP suggested_VBN a_DT special_JJ role_NN for_IN MMP-_NNP 2_CD
        in_IN tissue_NN invasion_NN ._. The_DT transcriptional_NN and_CC
        post-translational_JJ activation_NN of_IN this_DT enzyme_NN is_VBZ tightly_RB
        regulated_VBN [_NN 16_CD ]_NN ._. MMP-_NNP 2_CD differs_VBZ from_IN several_JJ other_JJ members_NNS
        of_IN the_DT metalloproteinase_NN family_NN in_IN that_DT its_PRP$ transcription_NN
        is_VBZ not_RB induced_VBN in_IN response_NN to_TO the_DT proinflammatory_NN cytokines_NNS
        tumor_NN necrosis_NNS factor-α_JJ and_CC interleukin-_NN 1_CD ,_, and_CC seems_VBZ
        primarily_RB regulated_VBN post-translationally_JJ ._. As_IN is_VBZ
        characteristic_NN of_IN most_JJS of_IN the_DT MMPs_NNP ,_, MMP-_NNP 2_CD is_VBZ produced_VBN as_IN a_DT
        proenzyme_NN ,_, and_CC requires_VBZ activation_NN by_IN enzymatic_JJ cleavage_NN ._.
        Evidence_NN from_IN several_JJ investigators_NNS has_VBZ suggested_VBN that_IN
        MMP-_NNP 2_CD in_IN its_PRP$ active_JJ form_NN is_VBZ bound_VBN in_IN a_DT trimolecular_NN complex_JJ
        at_IN the_DT cell_NN surface_NN [_NN 39_CD ,_, 40_CD ,_, 41_CD ,_, 42_CD ]_NN ._. Pro-_NNP MMP-_NNP 2_CD complexed_JJ
        with_IN TIMP-_NNP 2_CD binds_NNS to_TO a_DT TIMP-_NNP 2_CD binding_JJ site_NN on_IN the_DT
        membrane-bound_JJ MMP-_NNP 14_CD receptor_NN ,_, and_CC through_IN a_DT
        conformational_NN change_NN the_DT catalytic_JJ domain_NN becomes_VBZ exposed_VBN
        forming_VBG the_DT active_JJ enzyme_NN complex_JJ ._. Upon_IN dissociation_NN from_IN
        the_DT MMP-_NNP 14_CD receptor_NN ,_, TIMP-_NNP 2_CD binds_NNS the_DT catalytic_JJ site_NN and_CC
        suppresses_NNS the_DT activity_NN ._. Thus_RB ,_, the_DT activity_NN of_IN MMP-_NNP 2_CD is_VBZ
        regulated_VBN locally_RB by_IN a_DT delicate_JJ balance_NN between_IN MMP-_NNP 14_CD
        activation_NN and_CC TIMP-_NNP 2_CD inhibition_NN ._. Studies_NNS have_VBP localized_JJ
        this_DT trimolecular_NN complex_JJ to_TO the_DT invadopodia_NN of_IN malignant_JJ
        cells_NNS at_IN sites_NNS of_IN tissue_NN invasion_NN into_IN stroma_NN [_NN 43_CD ,_, 44_CD ]_NN and_CC
        serum_NN levels_NNS and_CC high_JJ tissue_NN expression_NN levels_NNS of_IN active_JJ
        MMP-_NNP 2_CD are_VBP predictors_NNS of_IN disease_NN severity_NN and_CC shortened_VBN
        survival_NN in_IN several_JJ malignancies_NNS [_NN 15_CD ,_, 16_CD ]_NN ._.
        In_IN view_NN of_IN the_DT analogies_NNS between_IN erosion_NN formation_NN in_IN
        arthritis_NN and_CC tumor_NN invasion_NN in_IN cancer_NN ,_, we_PRP hypothesized_VBN
        that_WDT activated_VBN MMP-_NNP 2_CD and_CC possibly_RB MMP-_NNP 9_CD might_MD play_VB an_DT
        important_JJ role_NN in_IN the_DT early_JJ stages_NNS of_IN invasion_NN of_IN synovial_NN
        pannus_JJ into_IN bone_NN and_CC cartilage_NN ._. Synovial_NNP tissue_NN specimens_NNS
        obtained_VBN from_IN a_DT cohort_NN of_IN patients_NNS with_IN early_JJ synovitis_NNS
        were_VBD examined_VBN for_IN the_DT presence_NN of_IN MMP-_NNP 9_CD and_CC components_NNS of_IN
        the_DT MMP-_NNP 2_CD -_: associated_VBN trimolecular_NN complex_JJ ._. A_DT highly_RB
        sensitive_JJ zymographic_JJ technique_NN was_VBD used_VBN to_TO evaluate_VB tissue_NN
        levels_NNS of_IN active_JJ and_CC latent_NN MMP-_NNP 2_CD ._. Our_PRP$ immunohistologic_JJ
        data_NNS suggest_VBP that_IN MMP-_NNP 2_CD ,_, TIMP-_NNP 2_CD ,_, and_CC MMP-_NNP 14_CD are_VBP all_DT
        localized_VBN to_TO the_DT synovial_NN lining_NN layer_NN ._. Previous_JJ reports_NNS
        have_VBP found_VBN colocalization_NN of_IN these_DT molecules_NNS in_IN areas_NNS of_IN
        tissue_NN remodeling_NN ,_, loosening_NN of_IN prosthetic_JJ joints_NNS [_NN 45_CD ,_, 46_CD ,_,
        47_CD ]_NN ,_, and_CC in_IN the_DT cartilage-pannus_JJ junction_NN [_NN 14_CD ]_NN ._. Although_IN
        the_DT results_NNS of_IN these_DT experiments_NNS do_VBP not_RB prove_VB that_IN the_DT
        expression_NN of_IN these_DT molecules_NNS occurs_VBZ on_IN the_DT same_JJ cell_NN ,_, they_PRP
        are_VBP consistent_JJ with_IN the_DT view_NN that_IN the_DT synovial_NN lining_NN layer_NN
        is_VBZ a_DT site_NN of_IN MMP-_NNP 2_CD activation_NN ._.
        Because_IN of_IN the_DT blind_JJ nature_NN of_IN the_DT biopsy_NN technique_NN used_VBN
        in_IN the_DT present_JJ study_NN ,_, we_PRP did_VBD not_RB specifically_RB sample_NN areas_NNS
        of_IN synovium_NN directly_RB adjacent_JJ to_TO cartilage_NN and_CC bone_NN ._. We_PRP
        did_VBD ,_, however_RB ,_, ensure_VB that_IN all_DT of_IN the_DT needle_NN biopsy_NN samples_NNS
        examined_VBD immunohistologically_RB and_CC zymographically_RB had_VBD clear_JJ
        evidence_NN of_IN a_DT well-defined_JJ synovial_NN lining_NN layer_NN ,_, were_VBD of_IN
        adequate_JJ size_NN ,_, and_CC were_VBD thus_RB appropriate_JJ for_IN comparative_JJ
        evaluation_NN ._. The_DT selection_NN of_IN biopsy_NN material_NN with_IN
        detectable_JJ lining_NN layer_NN and_CC sufficiently_RB large_JJ size_NN for_IN
        analysis_NN may_MD have_VB biased_VBN our_PRP$ results_NNS toward_IN patients_NNS with_IN
        more_RBR proliferative_JJ synovial_NN lesions_NNS ,_, and_CC possibly_RB more_RBR
        severe_JJ disease_NN ._. This_DT selection_NN bias_NN would_MD have_VB occurred_VBN in_IN
        the_DT RA_NNP and_CC non-_NN RA_NNP patients_NNS ,_, however_RB ,_, and_CC is_VBZ therefore_RB
        unlikely_JJ to_TO account_VB for_IN the_DT differences_NNS seen_VBN in_IN MMP-_NNP 2_CD
        activity_NN between_IN the_DT patient_NN groups_NNS ._. We_PRP compared_VBD the_DT
        synovium_NN of_IN patients_NNS with_IN early_JJ RA_NNP with_IN that_DT of_IN patients_NNS
        with_IN other_JJ forms_NNS of_IN early_JJ synovitis_NNS ,_, and_CC with_IN that_DT of_IN
        normal_JJ volunteers_NNS ._. The_DT RA_NNP samples_NNS tended_VBD to_TO have_VB the_DT
        highest_JJS expression_NN levels_NNS of_IN MMP-_NNP 2_CD and_CC MMP-_NNP 14_CD ,_, but_CC they_PRP
        exhibited_VBN low_JJ levels_NNS of_IN TIMP-_NNP 2_CD expression_NN ._. More_RBR
        importantly_RB ,_, we_PRP showed_VBD that_IN the_DT patients_NNS with_IN radiographic_JJ
        erosions_NNS ,_, all_DT of_IN whom_WP had_VBD RA_NNP ,_, had_VBD the_DT highest_JJS levels_NNS of_IN
        active_JJ MMP-_NNP 2_CD by_IN gel_NN zymography_NN ._. We_PRP therefore_RB propose_VBP that_IN
        the_DT augmented_JJ levels_NNS of_IN activated_VBN MMP-_NNP 2_CD detected_VBD in_IN the_DT
        synovia_NN of_IN patients_NNS with_IN early_JJ erosive_JJ RA_NNP may_MD relate_VB ,_, at_IN
        least_JJS in_IN part_NN ,_, to_TO an_DT imbalance_NN between_IN activation_NN by_IN MMP-_NNP 14_CD
        and_CC inhibition_NN by_IN TIMP-_NNP 2_CD ._.
        Immunohistologically_NNP ,_, MMP-_NNP 9_CD expression_NN was_VBD clearly_RB
        higher_JJR in_IN inflamed_JJ synovium_NN than_IN in_IN normal_JJ synovium_NN ,_, where_WRB
        it_PRP was_VBD virtually_RB undetectable_JJ ._. Furthermore_RB ,_, MMP-_NNP 9_CD activity_NN
        levels_NNS tended_VBD to_TO be_VB higher_JJR in_IN the_DT synovial_NN samples_NNS of_IN
        patients_NNS with_IN radiographic_JJ erosions_NNS than_IN those_DT of_IN patients_NNS
        without_IN erosions_NNS ,_, but_CC the_DT measured_VBN values_NNS varied_VBD widely_RB in_IN
        the_DT specimens_NNS examined_VBD ._. The_DT focal_JJ expression_NN of_IN MMP-_NNP 9_CD in_IN
        these_DT synovial_NN tissues_NNS ,_, combined_VBN with_IN the_DT small_JJ number_NN of_IN
        samples_NNS examined_VBD ,_, might_MD have_VB contributed_VBN to_TO the_DT wide_JJ tissue_NN
        variations_NNS observed_VBD ._.
        Overall_RB ,_, the_DT present_JJ observations_NNS suggest_VBP an_DT association_NN
        between_IN the_DT presence_NN of_IN active_JJ synovial_NN gelatinases_NNS and_CC the_DT
        early_JJ development_NN of_IN erosive_JJ articular_NN damage_NN ._. Although_IN the_DT
        evidence_NN is_VBZ indirect_JJ ,_, these_DT data_NNS are_VBP consistent_JJ with_IN the_DT
        hypothesis_NNS that_IN high_JJ levels_NNS of_IN activated_VBN synovial_NN
        gelatinases_NNS reflect_VBP augmented_JJ synovial_NN invasiveness_NNS ;_: these_DT
        observations_NNS are_VBP similar_JJ to_TO those_DT made_VBN in_IN the_DT context_NN of_IN
        invasive_JJ cancers_NNS [_NN 16_CD ]_NN ._. Although_IN there_EX continues_VBZ to_TO be_VB
        controversy_NN regarding_VBG the_DT origins_NNS of_IN the_DT invasive_JJ cells_NNS at_IN
        the_DT junction_NN of_IN cartilage_NN /_NN bone_NN and_CC pannus_JJ ,_, considerable_JJ
        evidence_NN has_VBZ accumulated_VBN that_IN the_DT lining_NN cells_NNS in_IN RA_NNP
        synovium_NN exhibit_NN a_NNP '_POS transformed_VBN '_POS phenotype_NN that_WDT is_VBZ typical_JJ
        of_IN invasive_JJ cells_NNS [_NN 26_CD ,_, 48_CD ]_NN ._.
        We_PRP attempted_VBD to_TO evaluate_VB the_DT more_RBR readily_RB available_JJ
        serum_NN levels_NNS of_IN active_JJ MMPs_NNP as_IN predictors_NNS of_IN joint_JJ
        erosions_NNS ._. Overall_RB ,_, only_RB the_DT serum_NN levels_NNS of_IN MMP-_NNP 1_CD were_VBD
        significantly_RB associated_VBN with_IN erosions_NNS and_CC with_IN CRP_NNP levels_NNS ._.
        Persistent_NNP CRP_NNP elevation_NN in_IN RA_NNP patients_NNS has_VBZ been_VBN shown_VBN to_TO
        be_VB associated_VBN with_IN the_DT progression_NN of_IN radiographic_JJ erosions_NNS
        [_NN 49_CD ]_NN ,_, but_CC a_DT previous_JJ RA_NNP study_NN failed_VBD to_TO associate_JJ MMP-_NNP 1_CD
        levels_NNS with_IN erosions_NNS [_NN 50_CD ]_NN ._. In_IN general_JJ ,_, serum_NN levels_NNS of_IN
        MMPs_NNP have_VBP tended_VBN to_TO vary_VB widely_RB in_IN the_DT reported_VBN studies_NNS [_NN
        9_CD ,_, 11_CD ,_, 12_CD ,_, 51_CD ]_NN ,_, and_CC appear_VB not_RB to_TO be_VB of_IN prognostic_JJ value_NN ._.
        Furthermore_RB ,_, degranulation_NN of_IN platelets_NNS and_CC neutrophils_NNS may_MD
        contribute_VB to_TO the_DT elevation_NN of_IN serum_NN levels_NNS of_IN MMP-_NNP 2_CD and_CC
        MMP-_NNP 9_CD seen_VBN in_IN the_DT patients_NNS ,_, and_CC may_MD be_VB an_DT explanation_NN for_IN
        the_DT high_JJ baseline_NN level_NN in_IN the_DT serum_NN [_NN 52_CD ,_, 53_CD ]_NN ._. In_IN
        contrast_NN ,_, this_DT is_VBZ not_RB the_DT case_NN for_IN MMP-_NNP 1_CD ,_, because_IN no_DT blood_NN
        cell_NN carries_VBZ a_DT preformed_JJ secretory_NN granule_NN of_IN this_DT enzyme_NN
        and_CC this_DT may_MD explain_VB why_WRB MMP-_NNP 1_CD levels_NNS relate_VBP more_RBR closely_RB
        to_TO radiographic_JJ erosions_NNS ._. The_DT measurement_NN of_IN serum_NN MMP_NNP
        levels_NNS in_IN the_DT context_NN of_IN controlled_VBN therapy_NN trials_NNS has_VBZ not_RB
        been_VBN well_RB explored_JJ ._.
        In_IN the_DT present_JJ study_NN we_PRP provided_VBD evidence_NN that_IN active_JJ
        MMP-_NNP 2_CD complexes_NNS are_VBP expressed_VBN in_IN the_DT synovium_NN and_CC may_MD be_VB
        involved_VBN in_IN the_DT development_NN of_IN bony_NN erosions_NNS ._. Therapeutic_NNP
        strategies_NNS to_TO inhibit_VB a_DT broad_JJ spectrum_NN of_IN MMPs_NNP ,_, including_VBG
        MMP-_NNP 2_CD and_CC possibly_RB MMP-_NNP 9_CD ,_, may_MD therefore_RB present_VB a_DT more_RBR
        powerful_JJ approach_NN to_TO retard_VB or_CC prevent_VB early_JJ erosions_NNS in_IN
        patients_NNS with_IN an_DT inflammatory_JJ arthropathy_NN ._.
      
    
  
